{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:09Z","timestamp":1793927109208,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Research Ward Excellence Program, BRWEP","award":["BRWEP2024W014090210"],"award-info":[{"award-number":["BRWEP2024W014090210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05618-7","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:13:22Z","timestamp":1783152802000},"page":"3653-3674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pentraxin 3 is an inflammation-related biomarker that distinguishes early-stage from mid-advanced cardiovascular-kidney-metabolic syndrome"],"prefix":"10.1007","volume":"481","author":[{"given":"Zhen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"20","key":"5618_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Rajgopal Singh R, Elkind MSV, American Heart Association (2023) Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circ 148(20):1606\u20131635. https:\/\/doi.org\/10.1161\/CIR.0000000000001184","journal-title":"Circ"},{"issue":"12","key":"5618_CR2","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1007\/s11010-025-05379-9","volume":"480","author":"Z Xu","year":"2025","unstructured":"Xu Z, Yang S, Tan Y, Zhang Q, Wang H, Tao J, Liu Q, Wang Q, Feng W, Li Z, Wang C, Cui L (2025) Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review. Mol Cell Biochem 480(12):6039\u20136075. https:\/\/doi.org\/10.1007\/s11010-025-05379-9","journal-title":"Mol Cell Biochem"},{"issue":"16","key":"5618_CR3","doi-asserted-by":"publisher","first-page":"1612703","DOI":"10.3389\/fimmu.2025.1612703","volume":"4","author":"A Roy","year":"2025","unstructured":"Roy A, Zeller J, Nero TL, Klepetko J, Eisenhardt SU, Parker MW, McFadyen JD, Peter K (2025) C-reactive protein: the nexus between inflammation and protein misfolding diseases. Front Immunol 4(16):1612703","journal-title":"Front Immunol"},{"issue":"17","key":"5618_CR4","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.3390\/ijms26178256","volume":"26","author":"C Carollo","year":"2025","unstructured":"Carollo C, Sorce A, Cirafici E, Ciuppa ME, Mul\u00e8 G, Caimi G (2025) Silent inflammation, loud consequences: decoding NLR across renal, cardiovascular and metabolic disorders. Int J Mol Sci 26(17):8256","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5618_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12902-024-01637-x","volume":"24","author":"HL Chen","year":"2024","unstructured":"Chen HL, Wu C, Cao L, Wang R, Zhang TY, He Z (2024) The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord 24(1):107","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"5618_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/0886022X.2019.1595645","volume":"41","author":"R Yoshitomi","year":"2019","unstructured":"Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Katafuchi E, Seki M, Tsuda S, Nakano T, Tsuruya K, Kitazono T (2019) High neutrophil\/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail 41(1):238\u2013243","journal-title":"Ren Fail"},{"issue":"47","key":"5618_CR7","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1093\/eurheartj\/ehad649","volume":"44","author":"J Luo","year":"2023","unstructured":"Luo J, Thomassen JQ, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R (2023) Neutrophil counts and cardiovascular disease. Eur Heart J 44(47):4953\u20134964","journal-title":"Eur Heart J"},{"key":"5618_CR8","unstructured":"Yu L, Sun J, Liu X (2023) Serum C reactive protein and procalcitonin are valuable predictors of coronary heart disease and poor prognosis in the elderly. Am J Transl Res. 15(6):4188\u20134195. PMID: 37434846; PMCID: PMC10331649."},{"key":"5618_CR9","doi-asserted-by":"publisher","unstructured":"Bontekoe J, Bansal V, Lee J, Syed M, Hoppensteadt D, Maia P, Walborn A, Liles J, Vasaiwala S, Fareed J (2020) Procalcitonin as a marker of comorbid atrial fibrillation in chronic kidney disease and history of sepsis. Clin Appl Thromb Hemost. 26:1076029620932228. https:\/\/doi.org\/10.1177\/1076029620932228. PMID: 32539447; PMCID: PMC7427007.","DOI":"10.1177\/1076029620932228"},{"issue":"14","key":"5618_CR10","doi-asserted-by":"publisher","first-page":"1274634","DOI":"10.3389\/fimmu.2023.1274634","volume":"9","author":"AM Massimino","year":"2023","unstructured":"Massimino AM, Colella FE, Bottazzi B, Inforzato A (2023) Structural insights into the biological functions of the long pentraxin PTX3. Front Immunol 9(14):1274634","journal-title":"Front Immunol"},{"issue":"1","key":"5618_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/imr.12476","volume":"274","author":"K Daigo","year":"2016","unstructured":"Daigo K, Inforzato A, Barajon I, Garlanda C, Bottazzi B, Meri S, Mantovani A (2016) Pentraxins in the activation and regulation of innate immunity. Immunol Rev 274(1):202\u2013217","journal-title":"Immunol Rev"},{"issue":"1","key":"5618_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.smim.2013.05.002","volume":"25","author":"A Inforzato","year":"2013","unstructured":"Inforzato A, Doni A, Barajon I, Leone R, Garlanda C, Bottazzi B, Mantovani A (2013) PTX3 as a paradigm for the interaction of pentraxins with the complement system. Semin Immunol 25(1):79\u201385. https:\/\/doi.org\/10.1016\/j.smim.2013.05.002","journal-title":"Semin Immunol"},{"key":"5618_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/bs.acc.2019.03.005","volume":"91","author":"A Zlibut","year":"2019","unstructured":"Zlibut A, Bocsan IC, Agoston-Coldea L (2019) Pentraxin-3 and endothelial dysfunction. Adv Clin Chem 91:163\u2013179. https:\/\/doi.org\/10.1016\/bs.acc.2019.03.005. (Epub 2019 May 4 PMID: 31331488)","journal-title":"Adv Clin Chem"},{"issue":"3","key":"5618_CR14","doi-asserted-by":"publisher","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T Kawai","year":"2021","unstructured":"Kawai T, Autieri MV, Scalia R (2021) Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol 320(3):C375\u2013C391. https:\/\/doi.org\/10.1152\/ajpcell.00379.2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"20","key":"5618_CR15","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.15420\/ecr.2025.33","volume":"17","author":"CH Grant","year":"2025","unstructured":"Grant CH, Bell S (2025) Obesity and chronic kidney disease: the dual epidemic in cardiovascular health. Eur Cardiol 17(20):e28","journal-title":"Eur Cardiol"},{"issue":"1","key":"5618_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes, and related disorders. Immunity 55(1):31\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.013. (PMID: 35021057; PMCID: PMC8773457)","journal-title":"Immunity"},{"issue":"12","key":"5618_CR17","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1253\/circj.cj-11-1184","volume":"75","author":"I Manabe","year":"2011","unstructured":"Manabe I (2011) Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 75(12):2739\u20132748. https:\/\/doi.org\/10.1253\/circj.cj-11-1184. (Epub 2011 Nov 8. PMID: 22067929)","journal-title":"Circ J"},{"issue":"1","key":"5618_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40101-025-00396-5","volume":"44","author":"BM Kim","year":"2025","unstructured":"Kim BM, Ryu SY, Han MA, Choi SW (2025) Loss of significant association between high-sensitivity C-reactive protein (hs-CRP) and metabolic syndrome after adjustment for waist circumference found in 2022 Korea National Health and Nutrition Examination Survey data. J Physiol Anthropol 44(1):16. https:\/\/doi.org\/10.1186\/s40101-025-00396-5. (PMID: 40474309; PMCID: PMC12139091)","journal-title":"J Physiol Anthropol"},{"key":"5618_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1661563","volume":"12","author":"J Nzobokela","year":"2025","unstructured":"Nzobokela J, Muchaili L, Mwambungu A, Masenga SK, Kirabo A (2025) Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome. Front Cardiovasc Med 12:1661563. https:\/\/doi.org\/10.3389\/fcvm.2025.1661563. (PMID: 41235339; PMCID: PMC12605086)","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"5618_CR20","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1210\/jc.2010-0305","volume":"95","author":"A Abbasi","year":"2010","unstructured":"Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans RO, Struck J, Hillege HL, Stolk RP, Navis G, Bakker SJ (2010) Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocrinol Metab 95(9):E26-31. https:\/\/doi.org\/10.1210\/jc.2010-0305. (Epub 2010 Jun 9 PMID: 20534760)","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5618_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/ac.70.4.3096896","volume":"70","author":"A Canbay","year":"2015","unstructured":"Canbay A, Celebi OO, Celebi S, Aydogdu S, Diker E (2015) Procalcitonin: a marker of heart failure. Acta Cardiol 70(4):473\u2013478. https:\/\/doi.org\/10.1080\/ac.70.4.3096896. (PMID: 26455251)","journal-title":"Acta Cardiol"},{"issue":"1","key":"5618_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejim.2014.12.009","volume":"26","author":"MP Villanueva","year":"2015","unstructured":"Villanueva MP, Mollar A, Palau P, Carratal\u00e1 A, N\u00fa\u00f1ez E, Santas E, Bod\u00ed V, Chorro FJ, Mi\u00f1ana G, Blasco ML, Sanchis J, N\u00fa\u00f1ez J (2015) Procalcitonin and long-term prognosis after an admission for acute heart failure. Eur J Intern Med 26(1):42\u201348. https:\/\/doi.org\/10.1016\/j.ejim.2014.12.009","journal-title":"Eur J Intern Med"},{"issue":"10","key":"5618_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2217\/bmm-2017-0160","volume":"11","author":"N Cvetinovic","year":"2017","unstructured":"Cvetinovic N, Isakovic AM, Lainscak M, Dungen HD, Nikolic NM, Loncar G (2017) Procalcitonin in heart failure: hic et nunc. Biomark Med 11(10):893\u2013903. https:\/\/doi.org\/10.2217\/bmm-2017-0160","journal-title":"Biomark Med"},{"issue":"5","key":"5618_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/1354750X.2018.1443511","volume":"23","author":"L A\u00efssou","year":"2018","unstructured":"A\u00efssou L, Sorbets E, Lallmahomed E, Goudot FX, Pop N, Es-Sebbani S, Benouda L, Nuel G, Meune C (2018) Prognostic and diagnostic value of elevated serum concentration of procalcitonin in patients with suspected heart failure. A review and meta-analysis. Biomarkers 23(5):407\u2013413. https:\/\/doi.org\/10.1080\/1354750X.2018.1443511","journal-title":"Biomarkers"},{"issue":"2","key":"5618_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23065","volume":"34","author":"SC Wu","year":"2020","unstructured":"Wu SC, Liang CX, Zhang YL, Hu WP (2020) Elevated serum procalcitonin level in patients with chronic kidney disease without infection: a case-control study. J Clin Lab Anal 34(2):e23065. https:\/\/doi.org\/10.1002\/jcla.23065","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"5618_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/cvr\/cvad012.PMID:36651911;PMCID:PMC10202646","volume":"119","author":"Z Xu","year":"2023","unstructured":"Xu Z, Gao Z, Fu H, Zeng Y, Jin Y, Xu B, Zhang Y, Pan Z, Chen X, Zhang X, Wang X, Yan H, Yang X, Yang B, He Q, Luo P (2023) PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications. Cardiovasc Res 119(5):1250\u20131264. https:\/\/doi.org\/10.1093\/cvr\/cvad012.PMID:36651911;PMCID:PMC10202646","journal-title":"Cardiovasc Res"},{"issue":"1","key":"5618_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ahj.2007.08.013","volume":"155","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, Sagara M, Kubota I (2008) Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J 155(1):75\u201381. https:\/\/doi.org\/10.1016\/j.ahj.2007.08.013","journal-title":"Am Heart J"},{"issue":"3","key":"5618_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/JME-21-0026","volume":"67","author":"TY Lin","year":"2021","unstructured":"Lin TY, Guo H, Chen X (2021) Unraveling mechanisms of pentraxin 3 secretion in adipocytes during inflammation. J Mol Endocrinol 67(3):55\u201369. https:\/\/doi.org\/10.1530\/JME-21-0026. (PMID: 34213423)","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"5618_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1523-1755.2005.67111.x","volume":"67","author":"AJ Nauta","year":"2005","unstructured":"Nauta AJ, de Haij S, Bottazzi B, Mantovani A, Borrias MC, Aten J, Rastaldi MP, Daha MR, van Kooten C, Roos A (2005) Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int 67(2):543\u2013553. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.67111.x. (PMID: 15673302)","journal-title":"Kidney Int"},{"issue":"8","key":"5618_CR30","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.3390\/ijms26083661.PMID:40332236;PMCID:PMC12027536","volume":"26","author":"RV Ahri\u021bculesei","year":"2025","unstructured":"Ahri\u021bculesei RV, Boldeanu L, Caragea DC, Vladu IM, Clenciu D, Mitrea A, Ungureanu AM, V\u0103duva CC, Dijm\u0103rescu AL, Popescu AIS, Assani MZ, Boldeanu MV, Vere CC (2025) Association between pentraxins and obesity in prediabetes and newly diagnosed Type 2 diabetes mellitus patients. Int J Mol Sci 26(8):3661. https:\/\/doi.org\/10.3390\/ijms26083661.PMID:40332236;PMCID:PMC12027536","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5618_CR31","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.xkme.2024.100800","volume":"6","author":"L Li","year":"2024","unstructured":"Li L, Liu H, Zhang Q, Jin H, Tao H, Chen H, Zhou Z (2024) Pentraxin-3 and Outcomes in CKD: A Systematic Review and Meta-analysis. Kidney Med 6(4):100800","journal-title":"Kidney Med"},{"issue":"6","key":"5618_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/jth.12557","volume":"12","author":"NS Jenny","year":"2014","unstructured":"Jenny NS, Blumenthal RS, Kronmal RA, Rotter JI, Siscovick DS, Psaty BM (2014) Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. J Thromb Haemost 12(6):999\u20131005","journal-title":"J Thromb Haemost"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05618-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05618-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05618-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:59Z","timestamp":1787908499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05618-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5618"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05618-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9249191\/v1","asserted-by":"object"}]},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Science Research Ethics Committee of Peking University Third Hospital (IRB00006761-M20250008). The requirement for informed consent was waived due to the minimal risk nature of the study and the use of anonymized residual serum samples obtained after routine clinical testing. All procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the publication of this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}